McKesson (MCK) Updates FY19 Earnings Guidance

McKesson (NYSE:MCK) issued an update on its FY19 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $13.00 -13.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $13.37. McKesson also updated its FY18 guidance to $12.50 -12.80 EPS.

NYSE:MCK traded up $2.82 during trading hours on Wednesday, hitting $151.71. The company’s stock had a trading volume of 1,462,744 shares, compared to its average volume of 1,746,240. The stock has a market capitalization of $30,606.31, a price-to-earnings ratio of 13.07, a PEG ratio of 1.36 and a beta of 1.32. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.61 and a current ratio of 1.07. McKesson has a 52-week low of $134.25 and a 52-week high of $178.86.

McKesson (NYSE:MCK) last released its quarterly earnings data on Thursday, February 1st. The company reported $3.41 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.92 by $0.49. The firm had revenue of $53.62 billion during the quarter, compared to analysts’ expectations of $51.98 billion. McKesson had a return on equity of 22.98% and a net margin of 2.34%. McKesson’s revenue was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $3.04 earnings per share. analysts predict that McKesson will post 12.69 EPS for the current year.



The company also recently announced a quarterly dividend, which was paid on Monday, April 2nd. Shareholders of record on Thursday, March 1st were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.90%. The ex-dividend date of this dividend was Wednesday, February 28th. McKesson’s dividend payout ratio (DPR) is 11.71%.

Several analysts have weighed in on the company. Needham & Company LLC upped their target price on McKesson from $173.00 to $180.00 and gave the company a buy rating in a report on Tuesday, January 23rd. Robert W. Baird reissued a buy rating and issued a $200.00 target price on shares of McKesson in a report on Wednesday, January 17th. Mizuho set a $186.00 target price on McKesson and gave the company a hold rating in a report on Wednesday, January 24th. Jefferies Group raised McKesson from a hold rating to a buy rating and set a $205.00 target price on the stock in a report on Wednesday, January 24th. Finally, Credit Suisse Group reissued a sell rating and issued a $130.00 target price on shares of McKesson in a report on Friday, February 2nd. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and nine have given a buy rating to the company. The company presently has a consensus rating of Hold and a consensus target price of $176.32.

In related news, SVP Erin M. Lampert sold 1,413 shares of the stock in a transaction on Thursday, March 1st. The stock was sold at an average price of $149.38, for a total transaction of $211,073.94. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.20% of the stock is owned by company insiders.

ILLEGAL ACTIVITY NOTICE: “McKesson (MCK) Updates FY19 Earnings Guidance” was first published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece on another site, it was illegally copied and republished in violation of international copyright and trademark laws. The correct version of this piece can be read at https://stocknewstimes.com/2018/04/25/mckesson-mck-updates-fy19-earnings-guidance.html.

McKesson Company Profile

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.

Earnings History and Estimates for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply